Financials data is unavailable for this security.
View more
Year on year Nanjing Vishee Medical Technology Co Ltd grew revenues 43.72% from 321.62m to 462.22m while net income improved 45.22% from 93.83m to 136.26m.
Gross margin | 70.21% |
---|---|
Net profit margin | 26.70% |
Operating margin | 28.72% |
Return on assets | 6.41% |
---|---|
Return on equity | 7.04% |
Return on investment | 6.92% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Nanjing Vishee Medical Technology Co Ltd fell by 93.87m. However, the company earned 134.20m from its operations for a Cash Flow Margin of 29.03%. In addition the company used 164.11m on investing activities and also paid 63.96m in financing cash flows.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 16.83 |
---|---|
Tangible book value per share | 14.81 |
More ▼
Balance sheet in CNYView more
Current ratio | 8.60 |
---|---|
Quick ratio | 8.31 |
Total debt/total equity | 0.0003 |
---|---|
Total debt/total capital | 0.0003 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 118.99% and 45.83%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | -- |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 90.64% |
EPS growth(5 years) | 10.03 |
---|---|
EPS (TTM) vs TTM 1 year ago | -14.95 |
More ▼